ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.5152+15A>G

gnomAD frequency: 0.00003  dbSNP: rs750905289
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000439630 SCV000512315 likely benign not specified 2016-12-19 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV000496840 SCV000636012 likely benign Hereditary breast ovarian cancer syndrome 2024-02-01 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000580343 SCV000683259 likely benign Hereditary cancer-predisposing syndrome 2016-08-05 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000588153 SCV000699208 uncertain significance not provided 2017-05-30 criteria provided, single submitter clinical testing Variant summary: The BRCA1 c.5152+15A>G variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in the ExAC dataset in 1/118024 control chromosomes at a frequency of 0.0000085, which does not exceed the estimated maximal expected allele frequency of a pathogenic BRCA1 variant (0.0010005). Additionaly, in gnomAD, the variant was identified at a low frequency as well (0.000012; 3/245902 chrs tested). In addition, one clinical diagnostic laboratory classified this variant as "Likely Benign". Taken together, this variant is classified as VUS-Possibly Benign.
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000439630 SCV001156830 likely benign not specified 2019-02-11 criteria provided, single submitter clinical testing
Cancer Genetics and Genomics Laboratory, British Columbia Cancer Agency RCV000496840 SCV000586907 uncertain significance Hereditary breast ovarian cancer syndrome 2016-04-14 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.